Relugolix 737789-87-6

Kufotokozera Kwachidule:

Dzina la API Chizindikiro Kufotokozera US DMF EU DMF CEP
Ribociclib CAS: 737789-87-6 Antineoplastic M'nyumba      


Tsatanetsatane wa Zamalonda

Zolemba Zamalonda

PRODUCT DETAIL

Relugolix amagwiritsidwa ntchito pochiza khansa ya prostate mwa amuna.
Dzina la Brand: Orgovyx
Gulu la Mankhwala: Antineoplastic - LHRH (GnRH) Antagonist Pituitary Suppressants
Kapezekedwe: Dongosolo Lofunika
Mimba: Funsani dokotala wanu.Mankhwalawa akhoza kukhala ovulaza kwa mwana wosabadwa.
Kuyamwitsa: Funsani dokotala musanagwiritse ntchito

Relugolix ndi mdani wopezeka pakamwa, wopanda peptide gonadotropin-release hormone (GnRH kapena luteinizing hormone-releasing hormone (LHRH))) wotsutsa, wokhala ndi zochita za antineoplastic.Relugolix mopikisana amamanga ndi kutsekereza cholandilira cha GnRH mu anterior pituitary gland, zomwe zonse zimalepheretsa GnRH kumangirira ku GnRH receptor ndikuletsa kutulutsa ndi kutulutsa kwa onse a luteinizing hormone (LH) ndi follicle stimulating hormone (FSH).Kwa amuna, kuletsa kwa LH kulepheretsa kutulutsidwa kwa testosterone kuchokera ku maselo a Leydig mu testes.Popeza testosterone imafunika kuti prostate ikule, kuchepetsa milingo ya testosterone kumatha kulepheretsa kuchuluka kwa maselo a khansa ya prostate omwe amadalira mahomoni.

Relugolix ndi gonadotropin-release hormone (GnRH) receptor antagonist yomwe imagwiritsidwa ntchito pochiza matenda angapo omwe amakhudzidwa ndi mahomoni.Idavomerezedwa koyamba ku Japan mu 2019, pansi pa dzina la Relumina, pochiza matenda a uterine fibroids, ndipo posachedwa ndi United States' FDA mu 2020, pansi pa dzina la Orgovyx, pochiza khansa ya prostate.Relugolix adaphunziranso pochiza symptomatic ya endometriosis.Relugolix ndiye woyamba (ndipo pano yekha) yemwe amalandila pakamwa GnRH receptor antagonist wovomerezeka kuti azichiza khansa ya prostate - machiritso ofanana ngati [degarelix] amafunikira subcutaneous management - motero amapereka chithandizo chochepa cholemetsa kwa odwala omwe angafunike kupita kuchipatala. zoyendetsedwa ndi akatswiri azaumoyo.Kuphatikiza pa kugwiritsa ntchito kwake kosavuta, relugolix adawonetsedwa kuti ndi wapamwamba kwambiri pakupsinjika kwa milingo ya testosterone poyerekeza ndi [leuprolide], mankhwala ena oletsa androgen omwe amagwiritsidwa ntchito pochiza khansa ya prostate.

Relugolix ndi Gonadotropin Releasing Hormone Receptor Antagonist.Limagwirira ntchito ya relugolix ndi monga Gonadotropin Kutulutsa Hormone Receptor Antagonist, ndi Cytochrome P450 3A Inducer, ndi Cytochrome P450 2B6 Inducer, ndi Breast Cancer Resistance Protein Inhibitor, ndi P-Glycoprotein Inhibitor.Mphamvu ya physiologic ya relugolix imachokera ku Kuchepetsa kwa GnRH Secretion.

Kapangidwe ka mankhwala

ghdfg

CERTIFICATE

2018 GMP-2
原料药GMP证书201811(captopril ,thalidomide etc)
GMP-of-PMDA-in-Chanyoo-平成28年08月03日 Nantong-Chanyoo-Pharmatech-Co
FDA-EIR-Letter-201901

KUSINTHA KWA KHALIDWE

Quality management1

Malingaliro18Ma projekiti a Quality Consistency Evaluation omwe avomereza4,ndi6mapulojekiti akuvomerezedwa.

Quality management2

Njira zotsogola zapadziko lonse lapansi zoyendetsera bwino zakhazikitsa maziko olimba pakugulitsa.

Quality management3

Kuyang'anira kwabwino kumayendera nthawi yonse ya moyo wa chinthucho kuti zitsimikizire kuti zabwino ndi zochiritsira.

Quality management4

Gulu la Professional Regulatory Affairs limathandizira zofunikira pakufunsira ndikulembetsa.

MANAGEMENT ZOPHUNZITSA

cpf5
cpf6

Korea Countec Bottled Packaging Line

cpf7
cpf8

Taiwan CVC Bottled Packaging Line

cpf9
cpf10

Italy CAM Board Packaging Line

cpf11

German Fette Compacting Machine

cpf12

Japan Viswill Tablet Detector

cpf14-1

Chipinda chowongolera cha DCS

WOTHANDIZA

Mgwirizano wapadziko lonse lapansi
International cooperation
Mgwirizano wapakhomo
Domestic cooperation

  • Zam'mbuyo:
  • Ena:

  • Lembani uthenga wanu apa ndikutumiza kwa ife